Becton Dickinson and

227.36
-1.35 (-0.59%)
At close: Mar 28, 2025, 3:59 PM
226.44
-0.40%
After-hours: Mar 28, 2025, 06:42 PM EDT

Becton Dickinson and Revenue Breakdown

Quarter Sep 30, 2024Jun 30, 2024Mar 31, 2024Dec 31, 2023Sep 30, 2023Jun 30, 2023Mar 31, 2023Dec 31, 2022Sep 30, 2022Jun 30, 2022Mar 31, 2022Dec 31, 2021Sep 30, 2021Jun 30, 2021Mar 31, 2021Dec 31, 2020Sep 30, 2020Jun 30, 2020Mar 31, 2020Dec 31, 2019Sep 30, 2019Jun 30, 2019Mar 31, 2019Dec 31, 2018Sep 30, 2018Jun 30, 2018Mar 31, 2018Dec 31, 2017Sep 30, 2017Jun 30, 2017Mar 31, 2017Dec 31, 2016Sep 30, 2016Jun 30, 2016Mar 31, 2016Dec 31, 2015Sep 30, 2015Jun 30, 2015Mar 31, 2015Dec 31, 2014Sep 30, 2014Jun 30, 2014Mar 31, 2014Dec 31, 2013Sep 30, 2013Jun 30, 2013Mar 31, 2013Dec 31, 2012Sep 30, 2012Jun 30, 2012Mar 31, 2012Dec 31, 2011Sep 30, 2011Jun 30, 2011
Interventional Revenue 4.04B 2.1B 1.3B 1.29B 0 1.22B 1.19B 1.13B 0 1.14B 1.49B 1.11B 0 1.43B 1.01B 1.98B 0 782M 990M 1.01B 0 981M 963M 970M 1.13B 954M 1.1B 1.04B 1.05B 997M 982M 958M 997M 963M 936M 933M 2.08B 921M 945M 979M 301M 277M 302M 279M 300.69M 257.06M 279.36M 264.89M 155.31M 268.2M 339.61M 316.5M 1B 337.89M
Interventional Revenue Growth +92.24% +61.04% +1.24% n/a -100.00% +2.70% +5.05% n/a -100.00% -23.10% +33.18% n/a -100.00% +41.74% -48.91% n/a -100.00% -21.01% -2.17% n/a -100.00% +1.87% -0.72% -14.24% +18.55% -13.11% +5.07% -0.57% +5.42% +1.53% +2.51% -3.91% +3.53% +2.88% +0.32% -55.21% +126.17% -2.54% -3.47% +225.25% +8.66% -8.28% +8.24% -7.21% +16.97% -7.99% +5.46% +70.55% -42.09% -21.03% +7.30% -68.45% +196.92% n/a
Life Sciences Revenue 299M 2.3B 1.11B 1.05B 0 1.23B 1.27B 1.3B 0 1.31B 1.04B 1.48B 0 1.01B 1.59B 1.01B 0 951M 1.11B 1.12B 0 1.06B 1.05B 1.06B 1.11B 1.08B 2.17B 2.04B 2.12B 2.04B 1.99B 1.96B 2.23B 2.23B 2.13B 2.05B 977M 2.2B 1.11B 1.07B 1.9B 1.88B 1.77B 1.74B 1.15B 1.8B 2.05B 1.95B 2.01B 2.02B 1.96B 1.88B 5.71B 1.98B
Life Sciences Revenue Growth -87.00% +107.77% +5.23% n/a -100.00% -3.84% -2.07% n/a -100.00% +26.11% -30.01% n/a -100.00% -36.51% +57.34% n/a -100.00% -14.56% -0.89% n/a -100.00% +0.57% -0.38% -4.69% +2.69% -50.32% +6.73% -3.83% +3.83% +2.57% +1.17% -12.09% -0.04% +4.88% +3.75% +110.24% -55.57% +98.82% +3.17% -43.61% +1.12% +6.27% +1.90% +50.43% -35.73% -12.41% +4.99% -2.94% -0.47% +3.23% +4.41% -67.18% +188.95% n/a
Medical Revenue 5.82B n/a 489M 454M n/a 2.43B 2.36B 2.15B n/a 2.19B 450M 2.4B n/a 436M 2.31B 426M n/a 2.12B 2.15B 2.09B n/a 2.31B 2.18B 2.13B 2.16B 2.25B 952M n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Medical Revenue Growth n/a n/a +7.71% n/a n/a +3.14% +9.56% n/a n/a +386.89% -81.23% n/a n/a -81.13% +442.49% n/a n/a -1.35% +2.92% n/a n/a +6.01% +2.11% -1.29% -3.70% +135.92% n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a

Revenue by Geography

Quarter Sep 30, 2024Sep 30, 2023Sep 30, 2022Sep 30, 2021Sep 30, 2020Sep 30, 2019Sep 30, 2018Sep 30, 2017Sep 30, 2016Sep 30, 2015Sep 30, 2014Sep 30, 2013Sep 30, 2012Sep 30, 2010
Asia Revenue 2.91B 2.91B 3.05B 3.27B 2.57B 2.73B 2.46B 1.74B 1.69B 1.54B 1.12B 1.01B 883.29M 684.32M
Asia Revenue Growth -0.24% -4.40% -6.88% +27.41% -5.80% +10.81% +41.06% +3.07% +9.51% +37.82% +11.43% +13.89% +29.08% n/a
Europe Revenue 4.4B 4.24B 4.04B 4.75B 3.48B 3.36B 3.3B 2.59B 3.05B 2.43B 2.73B 2.51B 2.38B 2.39B
Europe Revenue Growth +3.72% +4.97% -14.90% +36.52% +3.60% +1.85% +27.43% -15.12% +25.27% -10.94% +8.80% +5.60% -0.34% n/a
Others Country Revenue 1.21B 1.1B 1.06B 1.25B 1.35B 1.48B 1.46B 1.26B 849M 1.23B 1.18B 1.18B 1.16B 1.01B
Others Country Revenue Growth +9.53% +4.16% -15.70% -7.24% -8.33% +1.30% +15.91% +48.06% -31.20% +5.02% -0.68% +2.10% +14.21% n/a
United States Revenue 11.66B 11.11B 10.72B 10.97B 9.72B 9.73B 8.77B 6.5B 6.89B 5.07B 3.42B 3.35B 3.29B 3.29B
United States Revenue Growth +4.95% +3.65% -2.25% +12.90% -0.14% +10.97% +34.81% -5.64% +35.98% +48.35% +1.91% +1.99% +0.03% n/a

Operating Expense Breakdown

Quarter Dec 31, 2024Sep 30, 2024Jun 30, 2024Mar 31, 2024Dec 31, 2023Sep 30, 2023Jun 30, 2023Mar 31, 2023Dec 31, 2022Sep 30, 2022Jun 30, 2022Mar 31, 2022Dec 31, 2021Sep 30, 2021Jun 30, 2021Mar 31, 2021Dec 31, 2020Sep 30, 2020Jun 30, 2020Mar 31, 2020Dec 31, 2019Sep 30, 2019Jun 30, 2019Mar 31, 2019Dec 31, 2018Sep 30, 2018Jun 30, 2018Mar 31, 2018Dec 31, 2017Sep 30, 2017Jun 30, 2017Mar 31, 2017Dec 31, 2016Sep 30, 2016Jun 30, 2016Mar 31, 2016Dec 31, 2015Sep 30, 2015Jun 30, 2015Mar 31, 2015
Selling, General, and Administrative Revenue 1.32B 1.26B 1.2B 1.19B 1.21B 1.14B 1.19B 1.21B 1.19B 1.18B 1.15B 1.23B 1.19B 1.33B 1.24B 1.15B 1.15B 1.2B 980M 1.02B 1.12B 1.09B 1.08B 1.09B 1.07B 1.1B 1.08B 1.06B 774M 774M 719M 724M 709M 796M 728M 732M 748M 756M 764M 511M
Selling, General, and Administrative Revenue Growth +4.94% +5.02% +0.25% -1.65% +6.68% -4.45% -1.24% +1.52% +0.42% +2.87% -6.74% +3.97% -11.04% +7.68% +7.75% -0.09% -4.25% +22.45% -4.39% -8.56% +2.47% +1.67% -1.19% +1.49% -2.72% +2.04% +2.27% +36.56% n/a +7.65% -0.69% +2.12% -10.93% +9.34% -0.55% -2.14% -1.06% -1.05% +49.51% n/a
Research and Development Revenue 343M 302M 299M 299M 290M 281M 306M 337M 313M 300M 315M 343M 314M 387M 344M 317M 291M 299M 262M 264M 270M 270M 282M 252M 258M 278M 277M 260M 192M 221M 186M 187M 182M 253M 207M 182M 187M 196M 178M 129M
Research and Development Revenue Growth +13.58% +1.00% n/a +3.10% +3.20% -8.17% -9.20% +7.67% +4.33% -4.76% -8.16% +9.24% -18.86% +12.50% +8.52% +8.93% -2.68% +14.12% -0.76% -2.22% n/a -4.26% +11.90% -2.33% -7.19% +0.36% +6.54% +35.42% -13.12% +18.82% -0.53% +2.75% -28.06% +22.22% +13.74% -2.67% -4.59% +10.11% +37.98% n/a